MaxCyte, Inc.MXCTNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank64
3Y CAGR-25.6%
5Y CAGR-23.2%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

3Y CAGR
-25.6%/yr
vs -31.9%/yr prior
5Y CAGR
-23.2%/yr
Consistent
Acceleration
+6.3pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 20256.90%
Q3 2025-19.72%
Q2 2025-18.12%
Q1 202519.52%
Q4 20246.48%
Q3 2024-21.72%
Q2 2024-8.05%
Q1 2024-27.59%
Q4 202395.71%
Q3 2023-11.49%
Q2 20235.45%
Q1 2023-30.97%
Q4 202216.73%
Q3 202210.77%
Q2 2022-17.08%
Q1 202214.14%
Q4 20210.13%
Q3 202142.64%
Q2 20219.44%
Q1 2021-23.72%
Q4 202025.90%
Q3 202031.30%
Q2 2020-10.30%
Q1 2020-13.31%
Q4 20190.00%
Q3 201958.21%
Q2 20190.00%
Q1 2019-14.01%
Q4 20180.00%
Q3 201840.51%
Q2 20180.00%
Q1 2018-10.87%
Q4 20170.00%
Q3 201725.20%
Q2 20170.00%
Q1 2017-8.71%
Q4 20160.00%
Q3 201624.42%
Q2 20160.00%
Q1 20167.34%